Hylla approves doctor's settlement in Accutane suit
A settlement by the last defendant in a long-running suit over an acne medication has been approved.
Madison County Circuit Judge David Hylla approved settlement stipulations filed by Dr. Daniel Goran and plaintiff Jason Peipert May 14.
The settlement amount was not disclosed in court records. Each party is to bear its own costs.
Peipert's suit against Goran, the last defendant standing in what was one of the first suits filed over Accutane and its alleged part in causing bowel disease, settled in April.
Two other defendants in the case, Hoffman-LaRoche Inc. and Roche Laboratories, settled in March for an undisclosed sum.
Peipert sued Goran for allegedly prescribing Accutane without warning Peipert of its effects and knowing it was difficult to manage in patients. Goran prescribed the drug in the late 1990s.
Peipert sued the drug's makers, the Roche defendants, over the product's alleged role in causing Peipert to develop inflammatory bowel disease.
Had the case gone to trial as originally scheduled in 2007, it would have been the first Accutane trial in the nation.
Accutane was taken off the market last year due to competition from generic forms, according to the Roche defendants.
The suit's trial moved off several times.
Hylla urged the parties to settle at a pre-trial conference in
February, citing the case's merits and its age.
Peipert was represented by John Papa, Walter Campbell and others.
Goran was represented by Jeffrey Glass and others.
The Roche defendants were represented by Bart Sullivan and others.
The case is Madison case number 03-L-2040.